Date: December 16, 2024
Time: 3:30 p.m.
The Neuroscience Biomarker Program is dedicated to advancing biomarkers for neurological disease. The program is focused on supporting research to promote biomarkers that will improve the quality and efficiency of Phase II clinical trials and clinical practice. The NINDS Biomarker Program provides support for biomarker and endpoint discovery, along with analytical and clinical validation in a manner that is consistent with FDA guidelines.
An interactive Q&A webinar will be held for interested applicants Monday, December 16, 2024 3:30 PM ET. All investigators who are interested in learning about the NINDS Biomarker funding opportunities are encouraged to participate. Investigators can find information about these funding opportunities at:
Biomarker Development
PAR-25-024: Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Analytical Validation
PAR-25-050 U01 Research Project – Cooperative Agreement
PAR-24-098 U44 SBIR Fast Track – Cooperative Agreement
Clinical Validation
PAR-25-055 U01 Research Project – Cooperative Agreement
PAR-24-096 U44 SBIR Fast Track – Cooperative Agreement
You can also submit questions before the meeting to Dr. Carol Taylor-Burds (carol.taylor-burds@nih.gov). While you can listen to the call on the phone, all questions will need to be submitted online.